Medication info
Bemlidia Tablet (Tenofovir Alafenamide Citrate)

Bemlidia Tablet (Tenofovir Alafenamide Citrate)

Prescription medicationTabletOral
Ingredient · strength
Tenofovir Alafenamide Citrate›35.08mg / 1 tablet
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202204504 · Approved 2022.12.15 · Insurance code 642507680

Summary

Main use
Treatment of chronic hepatitis B in adults
Who takes it
Adults
Adult dose
Take 1 tablet once daily, with or without food. No dosage adjustment is necessary in patients with mild, moderate, or severe renal impairment. Patients receiving chronic hemodialysis should take this medicine after dialysis on dialysis days. No dosage adjustment is necessary in patients with hepatic impairment.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Treatment of chronic hepatitis B in adults

  • Chronic hepatitis B
View approved original text

This medication is used for the treatment of chronic hepatitis B in adults.

How to take

Adult dose

Take 1 tablet once daily, with or without food. No dosage adjustment is necessary in patients with mild, moderate, or severe renal impairment. Patients receiving chronic hemodialysis should take this medicine after dialysis on dialysis days. No dosage adjustment is necessary in patients with hepatic impairment.

Precautions

This medication is used for the treatment of hepatitis B, and sudden discontinuation can lead to a rapid deterioration of hepatitis, so caution is needed. It should not be used in patients with allergies to any of its components or with genetic issues such as lactose intolerance. During treatment, side effects such as headache, abdominal pain, cough, back pain, fatigue, nausea, joint pain, diarrhea, and indigestion may occur; if symptoms persist, consult a doctor. Since it can affect kidney function, regular kidney function tests are required, especially in patients with existing kidney issues or those taking other nephrotoxic medications. Bone density reduction may occur, so patients at risk of osteoporosis should consider bone density testing. During pregnancy, the risk to the fetus is not significant; however, it should only be taken after sufficient consultation with a doctor during pregnancy, and with nursing mothers, the impact on the newborn should be considered before use. This medication is not recommended for the treatment of HIV-1 alone; appropriate combination therapy is needed after confirming HIV infection. Interactions with other drugs may occur, so caution is advised when used in combination with especially anticonvulsants, antituberculosis drugs, and natural products (such as St. John's Wort), and it is essential to inform healthcare professionals of any medications being taken. Elderly patients over 65 years of age or those with impaired kidney or liver function can use it without special dose adjustments, although medical supervision may be necessary based on their condition. In cases of overdose, vital signs and clinical status should be closely monitored, and if necessary, blood dialysis can be used to remove the drug. Store in a tightly sealed container to protect from air and moisture, and maintain a storage temperature between 1°C and 30°C.

Side effects

  • Headache
  • abdominal pain
  • cough
  • low back pain
  • fatigue
  • nausea
  • joint pain
  • diarrhea
  • dyspepsia
  • vomiting
Show 34 more
  • rash
  • gastrointestinal air retention
  • elevated amylase
  • elevated lipase
  • nausea
  • low back pain
  • abdominal tenderness
  • abdominal pain
  • abdominal distension
  • angioedema
  • hives
  • abdominal discomfort
  • constipation
  • discomfort in the upper abdomen
  • scallop-shaped stool
  • weakness
  • peripheral edema
  • chest discomfort
  • chills
  • cholelithiasis
  • cystitis
  • sinusitis
  • dizziness
  • muscle spasms
  • decrease in blood insulin
  • hair loss
  • eczema
  • splenomegaly
  • eosinophilia
  • macular degeneration
  • hypercholesterolemia
  • depression
  • palpitations
  • benign paroxysmal positional vertigo

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/bottle

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.